21-23 October 2026

Leiden - The Netherlands

Bayes 2026

DAY 1 - 21 October

TIME
SPEAKER
AFFILIATION

SHORT COURSE

09:00 - 12:30
Lukas Andreas Widmer
Novartis
Short Course "Applied Modelling in Drug Development with brms"
Sebastian Weber
Novartis

INVITED PLENARY SPEAKERS

John Scott
James Travis
FDA, CBER
FDA
FDA’s Bayesian Guidance and the Future of Bayes in Regulatory Submissions
Yuan Ji
University of Chicago
Setting and Reporting the Bayesian Decision Threshold under the FDA 2026 Draft Guidance: A Practical Workflow
Silvia Calderazzo
German Cancer Research Center (DKFZ)
A hybrid frequentist-Bayesian view on hypothesis testing in clinical trials borrowing external information
Anna Heath
University of Toronto (Dalla Lana School of Public Health) & The Hospital for Sick Children (SickKids)
Bayesian Trial Design in Paediatrics
Sofia Dias
University of York / NICE HTA (UK)
Borrowing strength across evidence sources in Health Technology Assessment: challenges and opportunities
Kevin Kunzmann
Boehringer-Ingelheim
From Hunch to Hedge: Applying Bayesian Thinking in Clinical Development Where It Matters Most
Marta Blangiardo
Imperial College London (UK)
A Bayesian hierarchical framework to evaluate policy effects through quasi-experimental designs in a longitudinal setting
Andrew Thomson
Regnitio (NL)
40 years of 'Why Isn't Everyone a Bayesian?" - a regulatory perspective

PANEL DISCUSSION

Panel discussion on Bayes in Regulatory Science

Panelists: Juan José Abellan (EMA), James Travis (FDA), Peter van de Ven (UMC Utrecht), Sebastian Weber (Novartis)
Moderators: Brad Carlin (PhaseV Trials), Sofia Villar (University of Cambridge)

CO-SPONSORED BY

Code of Conduct

The Adolphe Quetelet Society is an official region of the International Biometric Society (IBS). As such the society endorses the same objectives and Code of Conduct as its mother organization:

IBS Code of Conduct : The International Biometric Society (IBS) highly values professional and appropriate behavior at all times. This involves scientific and ethical integrity, as well as respectful conduct towards others regardless of gender, gender identity and expression, age, sexual orientation, disability, physical appearances, race, religion (or lack thereof) or beliefs.

Members of the IBS, as well as everyone employed on behalf of IBS or attending events organized by IBS, are expected to endorse this position and they agree to be considerate in speech and actions, to respect others, and to refrain from demeaning, discriminatory, or harassing behavior and speech, at all times.

All the participants of the BAYES2026 conference agree to adhere to the International Society for Bayesian Analysis (ISBA) Code of Conduct.  

Copyright © 2026 Bayes-Pharma